Glaxo Smith Kline Company Profile

Aggregated data from the web about Glaxo Smith Kline

Company Name	Glaxo Smith Kline
Website	https://us.gsk.com
Snippet	27 October 2021 GSK delivers strong Q3 sales of £9.1 billion +5% AER, +10% CER Total EPS 23.3p -7% AER, +3% CER; Adjusted EPS 36.6p +3% AER, +10% CER 2021 full year EPS guidance improved. 20 October 2021 US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices votes unanimously to recommend Shingrix for ...
Type	Public limited company
Founded	2000
Revenue	GB£34.099 billion[2] (2020)
Website	www.gsk.com
Industry	PharmaceuticalBiotechnologyConsumer goods
Products	Pharmaceuticals, vaccines, oral healthcare, nutritional products, over-the-counter medicines
Traded as	LSE: GSKNYSE: GSKFTSE 100 Component
Key people	Jonathan Symonds (Chairperson)Emma Walmsley (CEO)
Net income	GB£5.749 billion[2] (2020)
Area served	Worldwide
Headquarters	980 Great West Road, London, UK[1]
Predecessors	Glaxo Wellcome, SmithKline Beecham
Subsidiaries	Stiefel Laboratories, Tesaro, ViiV Healthcare (76.5%)
Total assets	GB£80.431 billion[2] (2020)
Total equity	GB£20.808 billion[2] (2020)
Operating income	GB£7.783 billion[2] (2020)
Number of employees	99,000 (2021)[3]

Glaxo Smith Kline is part of the United Kingdom company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.